Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Mutation Rate

Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_3912-2

Definition

The mutation rate is defined as the probability of a cell acquiring a mutation in a gene. This probability, abbreviated by the symbol “μ,” depends on specific parameters, such as the cell type and the gene, the effect of the mutation (e.g., gain of function, inactivation, or silent mutation), and the nature of the event (e.g., point mutation vs. translocation). Factors that influence μ include the fidelity of DNA polymerases, activity of repair pathways, and exposure to mutagens. μ can be expressed as the probability of a mutation occurring in a gene per cell division, as the probability of a mutation in a nucleotide pair per cell division, or as mutations per unit of time. A related parameter, the mutant frequency (f), represents the proportion of cells in a population harboring a mutation in a gene at any one point in time, whereas μ represents the rate of increase in fas a function of time or cell divisions. Because μ is typically a low number, it can be measured only...

Keywords

Mutation Rate Fanconi Anemia Ataxia Telangiectasia Resistant Coloni Bulk Culture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access

References

  1. Araten DJ, Golde DW, Zhang RH et al (2005) Quantitative measurement of the human somatic mutation rate. Cancer Res 65:8111–8117CrossRefPubMedGoogle Scholar
  2. Araten DJ, Martinez-Climent JA, Perle MA (2010) A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene. Mutat Res 686:1–8CrossRefPubMedPubMedCentralGoogle Scholar
  3. Glaab WE, Tindall KR (1997) Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis 18:1–8CrossRefPubMedGoogle Scholar
  4. Li R, Montpetit A, Rousseau M (2014) Somatic point mutations occurring early in development: a monozygotic twin study. J Med Genet 51:28–34CrossRefPubMedGoogle Scholar
  5. Luria, SE, Delbruck, M (1943) Mutations of Bacteria from virus sensitivity to virus resistance. Genetics 28:491-511Google Scholar
  6. Lynch M (2010) Rate, Molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci U S A 107:961–968CrossRefPubMedPubMedCentralGoogle Scholar
  7. Michor F, Iwasa Y, Vogelstein B et al (2005) Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol 15:43–49CrossRefPubMedGoogle Scholar
  8. Seshadri R, Kutlaca RJ, Trainor K et al (1987) Mutation rate of normal and malignant human lymphocytes. Cancer Res 47:407–440PubMedGoogle Scholar
  9. Sjoblom T, Jones S, Wood LD et al (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314:268–274CrossRefPubMedGoogle Scholar
  10. Welch JS, Ley TJ, Link DC et al (2012) The origin and evolution of mutations in acute myelogenous leukemia. Cell 150:265–278CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.NYU School of MedicineLaura and Isaac Perlmutter Cancer Center and the New York VA Medical CenterNew YorkUSA